Getinge AB
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage so… Read more
Market Cap & Net Worth: Getinge AB (GNGBF)
Getinge AB (PINK:GNGBF) has a market capitalization of $5.37 Billion ($5.37 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #3402 globally and #2243 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Getinge AB's stock price $21.11 by its total outstanding shares 254152000 (254.15 Million).
Getinge AB Market Cap History: 2015 to 2025
Getinge AB's market capitalization history from 2015 to 2025. Data shows growth from $4.87 Billion to $5.37 Billion (1.28% CAGR).
Getinge AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Getinge AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
Getinge AB's market cap is 0.12 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.64x
Getinge AB's market cap is 2.64 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.87 Billion | $30.23 Billion | $1.39 Billion | 0.16x | 3.50x |
| 2016 | $3.03 Billion | $29.76 Billion | $1.19 Billion | 0.10x | 2.55x |
| 2017 | $3.37 Billion | $22.50 Billion | $1.38 Billion | 0.15x | 2.45x |
| 2018 | $2.21 Billion | $24.17 Billion | -$967.00 Million | 0.09x | N/A |
| 2019 | $3.27 Billion | $26.56 Billion | $1.22 Billion | 0.12x | 2.68x |
| 2020 | $5.84 Billion | $29.82 Billion | $3.24 Billion | 0.20x | 1.80x |
| 2021 | $10.95 Billion | $27.05 Billion | $2.97 Billion | 0.40x | 3.69x |
| 2022 | $6.19 Billion | $28.29 Billion | $2.49 Billion | 0.22x | 2.48x |
| 2023 | $5.52 Billion | $31.83 Billion | $2.41 Billion | 0.17x | 2.29x |
| 2024 | $4.32 Billion | $34.76 Billion | $1.64 Billion | 0.12x | 2.64x |
Competitor Companies of GNGBF by Market Capitalization
Companies near Getinge AB in the global market cap rankings as of March 18, 2026.
Key companies related to Getinge AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Getinge AB Historical Marketcap From 2015 to 2025
Between 2015 and today, Getinge AB's market cap moved from $4.87 Billion to $ 5.37 Billion, with a yearly change of 1.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $5.37 Billion | +24.18% |
| 2024 | $4.32 Billion | -21.79% |
| 2023 | $5.52 Billion | -10.70% |
| 2022 | $6.19 Billion | -43.52% |
| 2021 | $10.95 Billion | +87.50% |
| 2020 | $5.84 Billion | +78.51% |
| 2019 | $3.27 Billion | +47.85% |
| 2018 | $2.21 Billion | -34.31% |
| 2017 | $3.37 Billion | +11.12% |
| 2016 | $3.03 Billion | -37.71% |
| 2015 | $4.87 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Getinge AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.37 Billion USD |
| MoneyControl | $5.37 Billion USD |
| MarketWatch | $5.37 Billion USD |
| marketcap.company | $5.37 Billion USD |
| Reuters | $5.37 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.